Growth Metrics

Bionano Genomics (BNGO) Shares Outstanding (Weighted Average) (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 850.47% to $12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Dec 2025, up 850.47% year-over-year, with the annual reading at $12.1 million for FY2025, 850.47% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $12.1 million in Q4 2025 for Bionano Genomics, roughly flat from $12.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $274.4 million in Q3 2021 to a low of $8000.0 in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $38.3 million across 5 years, with a median of $4.4 million in 2021.
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 4425.0% in 2023; the steepest drop was 98.47% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $436000.0 in 2021, then crashed by 98.17% to $8000.0 in 2022, then skyrocketed by 4425.0% to $362000.0 in 2023, then soared by 251.1% to $1.3 million in 2024, then surged by 850.47% to $12.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BNGO at $12.1 million in Q4 2025, $12.1 million in Q3 2025, and $3.1 million in Q2 2025.